RxDoctor Payments Data

Stephen Raterman, MD

Orthopaedic Surgery · Tampa, FLNPI 1073628731

Payments from drug & device makers

$320,537in general payments, 2019–2025

Across 276 payments — averaging $1161.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Omnilife Science, Inc$252K
  • Naviswiss, Inc.$56K
  • MVP Orthopedics Inc$3K
  • Stryker$3K
  • Smith+Nephew$3K
  • Corin USA$2K
  • plus $2K from 16 others
$25,960in research payments, 2019–2025

Across 16 payments — averaging $1622.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$15K
  • Corin USA$7K
  • Omnilife Science, Inc$4K

What the payments were for

  • Royalty or licence$229,89072%
  • Consulting fees$76,91524%
  • Travel & lodging$3,2071%
  • Food & beverage$8,2903%
  • Education$2,2351%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Omnilife Science, Inc79$251,552
Naviswiss, Inc.38$56,028
MVP Orthopedics Inc4$3,271
Stryker(2 entities)23$3,008
Smith+Nephew88$2,733
Corin USA12$2,442
Arthrex3$593
Coastal Medical Technologies LLC5$263
Exactech, Inc.2$143
Anika Therapeutics, Inc.1$75
Johnson & Johnson(2 entities)2$61
Pacira Therapeutics, Inc.3$50
Dynasplint Systems Inc.1$46
Bioventus LLC1$45
Sanara Medtech Inc.4$45
Heron Therapeutics, Inc.2$42
Acelrx Pharmaceuticals, Inc.2$37
Baxter Healthcare1$26
Theragen, Inc.2$25
Solventum Corporation1$21
Bard Access Systems, Inc.1$18
Fidia Pharma USA Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$320,537 in reported general payments places this provider in the 90th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$450,186
Medicare patients
624
Services billed
11,919

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin185$893
Cyclobenzaprine Hcl93$873
Celecoxib33$629
Meloxicam244$590
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen57$512
Methylprednisolone68$403
Diclofenac Sodium21$377
Etodolac ErEtodolac11$346
Cefadroxil36$185
Dexamethasone33$170
Ibuprofen18$115
Omeprazole38$111
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$101
Amoxicillin87$85
Tramadol Hcl32$69

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →